Current breast cancer therapies aren’t working

Pamela Egan Practical Practitioner


By: Pamela Egan, FNP-C CDE



Current Breast Cancer Therapies Aren’t Working



Has modern medicine gone anywhere in its attempts to treat breast cancer? The answer to this question lies with the politics of medicine, the industries that create pollutants, and the cancer industry.

Over the past few decades, conventional medicine has done very little to make any meaningful difference in what will happen to you if you get breast cancer, and virtually nothing it has done has reduced the incidence of the disease. Statistics clearly tell us that conventional medicines for treating breast cancer such as tamoxifen, radiation, and chemotherapy just aren’t working in the long run. If you have invasive or non-local breast cancer, your chances of dying from it are still about one in three, the same as they have been for decades.

The death rate from breast cancer is also staggering. If you combine mortality rates from the United States and Canada (which have the highest rates of breast cancer in the world), in North America a woman dies of breast cancer every 12 minutes.

There is a bizarre refusal in American medicine to admit that we pretty much know what causes cancer and how to prevent it, but we continue to “slash, poison, and burn” (as breast surgeon and author Susan Love, MD, so aptly termed surgery, chemotherapy, and radiation treatments) for breast cancer, even though they know that, in the end, the treatments are unlikely to make much positive difference in the lives of their patients.

Perhaps this blindness has to do with the fact that a healthcare provider can lose his or her medical license by deviating from the standard of care in medicine. This is particularly true in the area of cancer. Practitioners who try unapproved treatments or alternative medicine for cancer face quick and influential action from local medical boards and are labeled as quacks by their colleagues.

The probably cause of the rise in breast cancer deaths was the prescription of unopposed synthetic estrogen (not balanced with progesterone) to menopausal women. While the medical community acknowledged that this practice caused endometrial cancer, it never admitted that it also caused breast cancer. From the mid-1970’s, doctors were instructed to prescribe synthetic progestins along with the estrogen to prevent endometrial cancer. This practice has also been linked to the rise in breast cancer.

Of course the key to reducing the incidence of breast cancer is prevention, but prevention is cast aside in the breast cancer industry. For example, there’s no question that you can significantly reduce your risk by eating a wholesome diet, getting regular moderate exercise, maintaining a healthy weight, and managing stress effectively. Breast cancer is multi-factorial. Years of estrogen dominance or heavy exposure to pesticides or solvents may undo all the good practice of proper nutrition and exercise.

It may shock you to know that despite breast cancer being the leading cause of death among middle-aged women in the United States, only 5%of the National Cancer Institute’s budget is allocated to research on cancer prevention.

Interestingly, the taxpayer-financed Women’s Breast Cancer Initiative will be researching only pharmaceutical drugs (Premarin plus various synthetic estrogens and progestins) in relationship to breast cancer. This is like subsidizing the drug companies-which already make billions of dollars in profits after spending billions on advertising, public relations, and lobbying money to influence congressional decisions. Drug testing should be the responsibility of the drug companies, not taxpayers. Wouldn’t you rather see a study comparing plant based, bio-identical hormones balanced with natural progesterone as part of that study? We already know that conventional, synthetic hormones lead to breast cancer. For more information read, What Your Doctor May Not Tell You about Breast Cancer by John R. Lee, MD.


Recent Articles: > Health Articles > Cancer